青蒿素及其衍生物防治心血管疾病的研究进展

罗文宽; 卢健棋; 陈文鹏; 庞延; 潘朝锌; 温志浩

doi:10.6039/j.issn.1001-0408.2023.02.23

您当前的位置：

首页 >

文章列表页 >

青蒿素及其衍生物防治心血管疾病的研究进展

综述 | 更新时间：2023-02-22

- 青蒿素及其衍生物防治心血管疾病的研究进展
- Research progress of artemisinin and its derivatives in prevention and treatment of cardiovascular diseases
- 中国药房 2023年34卷第2期页码：246-250
- 作者机构：
  
  1.广西中医药大学研究生院，南宁　530001
  2.广西中医药大学第一附属医院心内科/国家中医心血管病临床医学研究中心分中心，南宁　530022
  3.云南中医药大学第二附属医院神经心血管科，昆明　650215
- 作者简介：
  
  硕士研究生。研究方向：中医药防治心血管疾病。E-mail：18026358859@163.com
  主任医师，教授，博士生导师。研究方向：中医药防治心血管疾病。E-mail：lujianqi666@163.com
- 基金信息：
  
  国家自然科学基金地区基金资助项目(82160887);广西自然科学基金资助项目(2021GXNSFBA196018);广西自然科学基金面上项目(2021GXNSFAA220111)
- DOI：10.6039/j.issn.1001-0408.2023.02.23
  中图分类号： R531.3;R972
- 纸质出版日期：2023-01-30，
  
  收稿日期：2022-09-05，
  
  修回日期：2022-12-24，
扫描看全文
罗文宽,卢健棋,陈文鹏等.青蒿素及其衍生物防治心血管疾病的研究进展 ^Δ[J].中国药房,2023,34(02):246-250.

LUO Wenkuan,LU Jianqi,CHEN Wenpeng,et al.Research progress of artemisinin and its derivatives in prevention and treatment of cardiovascular diseases[J].ZHONGGUO YAOFANG,2023,34(02):246-250.
罗文宽,卢健棋,陈文鹏等.青蒿素及其衍生物防治心血管疾病的研究进展 ^Δ[J].中国药房,2023,34(02):246-250. DOI： 10.6039/j.issn.1001-0408.2023.02.23.

LUO Wenkuan,LU Jianqi,CHEN Wenpeng,et al.Research progress of artemisinin and its derivatives in prevention and treatment of cardiovascular diseases[J].ZHONGGUO YAOFANG,2023,34(02):246-250. DOI： 10.6039/j.issn.1001-0408.2023.02.23.

摘要

青蒿素是从植物青蒿中分离出来的含过氧基团的倍半萜内酯，具有抗疟疾活性，是治疗疟疾的有效药物。随着人们对青蒿素研究的逐步深入，青蒿素及其衍生物在其他系统的药理作用也逐渐成为研究的热点。本文对青蒿素及其衍生物防治心血管疾病的研究进展进行了综述。青蒿素及其衍生物在心血管疾病的防治中显示出了抗动脉粥样硬化、降血脂、抑制血管重塑、降压、改善心室重构、抗心律失常、保护血管内皮、防治糖尿病心血管并发症及保护心肌细胞等药理作用，为高血压、心律失常、冠心病支架置入术后并发症、高脂血症等心内科常见疾病提供了新的治疗策略。但关于青蒿素及其衍生物的抗血小板聚集作用、抗血栓的研究较少，很多药理作用背后的分子机制尚未明确，且临床应用不多，仍然需要大量的基础研究和临床试验来解答这些问题。

Abstract

Artemisinin is a sesquiterpene lactone containing a peroxide group isolated from the plant

Artemisia annua

. It has antimalarial activity and is effective for the treatment of malaria. With the deepening of research on artemisinin， the pharmacological effects of artemisinin and its derivatives in other systems have gradually become a research hotspot. This article reviews the research progress of artemisinin and its derivatives in the prevention and treatment of cardiovascular diseases. Artemisinin and its derivatives in the prevention and treatment of cardiovascular disease have shown anti-atherosclerosis， lipid-lowering， inhibition of vascular remodeling， reducing vascular pressure， improving ventricular remodeling， anti-arrhythmia， protection of vascular endothelium， prevention and treatment of diabetic cardiovascular complications and protection of myocardial cells and other pharmacological effects. It provides a new treatment strategy for common cardiovascular diseases such as hypertension， arrhythmia， coronary heart disease complications after stent implantation， hyperlipidemia， etc. However， there are few studies on the antiplatelet aggregation and antithrombotic effects of artemisinin and its derivatives， the molecular mechanisms behind many pharmacological effects have not yet been clarified， and there is little clinical application. A large number of basic studies and clinical trials are still needed to answer these questions.

关键词

青蒿素衍生物心血管疾病药理作用

Keywords

derivativescardiovascular diseasepharmacological effect

references

TU Y Y. Artemisinin：a gift from traditional Chinese medicine to the world（Nobel lecture）[J]. Angew Chem Int Ed Engl，2016，55（35）：10210-10226.

蒋沅岐，董玉洁，周福军，等. 青蒿素及其衍生物的研究进展[J]. 中草药，2022，53（2）：599-608.

SEPTEMBRE-MALATERRE A，LALARIZO RAKOTO M，MARODON C，et al. Artemisia annua，a traditional plant brought to light[J]. Int J Mol Sci，2020，21（14）：4986.

ZHU Y H，XIAN X M，WANG Z Z，et al. Research pro-gress on the relationship between atherosclerosis and inflammation[J]. Biomolecules，2018，8（3）：80.

JIANG Y，DU H J，LIU X，et al. Artemisinin alleviates atherosclerotic lesion by reducing macrophage inflammation via regulation of AMPK/NF-κB/NLRP3 inflammasomes pathway[J]. J Drug Target，2020，28（1）：70-79.

HE L H，GAO J H，YU X H，et al. Artesunate inhibits athe-rosclerosis by upregulating vascular smooth muscle cells-derived LPL expression via the KLF2/NRF2/TCF7L2 pathway[J]. Eur J Pharmacol，2020，884：173408.

CAO Q，DU H J，FU X，et al. Artemisinin attenuated athe-rosclerosis in high-fat diet-fed ApoE－/－ mice by promo-ting macrophage autophagy through the AMPK/mTOR/ULK1 pathway[J]. J Cardiovasc Pharmacol，2020，75（4）：321-332.

DU H J，ZHAO Q，ZANG H B，et al. Artemisinin atte- nuates the development of atherosclerotic lesions by the regulation of vascular smooth muscle cell phenotype switching[J]. Life Sci，2019，237：116943.

JIANG W W，CEN Y Y，SONG Y，et al. Artesunate attenuated progression of atherosclerosis lesion formation alone or combined with rosuvastatin through inhibition of pro-inflammatory cytokines and pro-inflammatory chemokines[J]. Phytomedicine，2016，23（11）：1259-1266.

LEI Z L，WU H J，YANG Y H，et al. Dihydroartemisinin improves hypercholesterolemia in ovariectomized mice via enhancing vectorial transport of cholesterol and bile acids from blood to bile[J]. Bioorg Med Chem，2022，53：116520.

ZHOU H Y，YOU P D，LIU H，et al. Artemisinin and Procyanidins loaded multifunctional nano complexes alleviate atherosclerosis via simultaneously modulating lipid influx and cholesterol efflux[J]. J Control Release，2022，341：828-843.

QIAN Y，XIA L，WEI L，et al. Artesunate attenuates foam cell formation by enhancing cholesterol efflux[J]. Ann Transl Med，2021，9（17）：1379.

WANG Y L，WANG Z J，SHEN H L，et al. The hypolipide-mic effect of artesunate and ursolic acid in rats[J]. Pak J Pharm Sci，2015，28（3）：871-874.

戴龙圣，于洋.冠状动脉旁路移植术后大隐静脉桥血管再狭窄机制及防治策略研究新进展[J].心肺血管病杂志，2020，39（3）：357-359.

李永章，杨冰琦，高丽敏. 双氢青蒿素通过抑制炎症反应在血管重塑中的作用机制研究[J]. 中国现代应用药学，2022，39（9）：1174-1181.

FEIL S，HOFMANN F，FEIL R. SM22alpha modulates vascular smooth muscle cell phenotype during atherogene-sis[J]. Circ Res，2004，94（7）：863-865.

黄强信，周念，冯志强，等. 青蒿素对大鼠自体移植静脉桥内膜增生的影响[J]. 实用医学杂志，2021，37（23）：2993-2997.

WANG X Y，WU J P，ZHANG H Y，et al. Dihydroartemisinin ameliorates balloon injury-induced neointimal formation through suppressing autophagy in vascular smooth muscle cells[J]. Biol Chem，2020，402（4）：451-460.

JANG S，JEONG M H，LIM K S，et al. Effect of stents coated with artemisinin or dihydroartemisinin in a porcine coronary restenosis model[J]. Korean Circ J，2017，47（1）：115-122.

CHRISTOU H，KHALIL R A. Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies[J]. Am J Physiol Heart Circ Physiol，2022，322（5）：H702-H724.

BAO C L，HE Q，WANG H，et al. Artemisinin and its derivate alleviate pulmonary hypertension and vasoconstriction in rodent models[J]. Oxid Med Cell Longev，2022，2022：2782429.

TANG M，WANG R Y，FENG P P，et al. Dihydroartemi-sinin attenuates pulmonary hypertension through inhibition of pulmonary vascular remodeling in rats[J]. J Cardiovasc Pharmacol，2020，76（3）：337-348.

CAI H J，FAN S Q，CAI L Q，et al. Dihydroartemisinin attenuates hypoxia-induced pulmonary hypertension through the ELAVL2/miR-503/PI3K/Akt axis[J]. J Cardiovasc Pharmacol，2022，80（1）：95-109.

LI Y Z，CAI H J，WEI J Q，et al. Dihydroartemisinin attenuates hypoxic pulmonary hypertension via the downregulation of miR-335 targeting Vangl2[J]. DNA Cell Biol，2022，41（8）：750-767.

HUO Y B，GAO X，PENG Q，et al. Dihydroartemisinin alleviates AngⅡ-induced vascular smooth muscle cell proli-feration and inflammatory response by blocking the FTO/NR4A3 axis[J]. Inflamm Res，2022，71（2）：243-253.

LIU X X，WANG X X，PAN Y，et al. Artemisinin improves acetylcholine-induced vasodilatation in rats with primary hypertension[J].Drug Des Dev Ther，2021，15：4489-4502.

XU W X，LU C F，ZHANG F，et al. Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction[J]. FEBS J，2017，284（1）：114-133.

宋爱新，王璐，张媛媛. 青蒿素对心肌梗死大鼠心室重构的作用研究[J]. 中国临床药理学杂志，2020，36（10）：1233-1236.

REID B G，STRATTON M S，BOWERS S，et al. Disco-very of novel small molecule inhibitors of cardiac hypertrophy using high throughput，high content imaging[J]. J Mol Cell Cardiol，2016，97：106-113.

GU Y W，WANG X，WANG X，et al. Artemisinin atte- nuates post-infarct myocardial remodeling by down-regulating the NF-κB pathway[J]. Tohoku J Exp Med，2012，227（3）：161-170.

史钰芳，杨靖，苗思露. 青蒿素对心衰兔心功能及窦房结功能的影响[J]. 中国中医药科技，2020，27（1）：31-34.

GU Y W，WU G，WANG X，et al. Artemisinin prevents electric remodeling following myocardial infarction possibly by upregulating the expression of connexin 43[J]. Mol Med Rep，2014，10（4）：1851-1856.

XU X，ZHANG Q，SONG H Q，et al. Effects of artemi-sinin on ventricular arrhythmias in response to left ventricular afterload increase and microRNA expression profiles in Wistar rats[J]. PeerJ，2018，6：e6110.

李敏，张乐曙，周洁茹，等. 青蒿素和胺碘酮对大鼠心律失常作用的对比研究[J]. 重庆医学，2020，49（6）：883-886.

范铁兵，李运伦，丁书文. 丁书文运用青蒿、常山治疗心律失常的研究[J]. 国医论坛，2020，35（1）：52-54.

袁向科，江瑞. 青蒿素对氧化低密度脂蛋白诱导的血管内皮细胞损伤的作用及机制[J]. 解放军医学杂志，2021，46（4）：333-339.

WANG P，TIAN X Y，TANG J X，et al. Artemisinin protects endothelial function and vasodilation from oxidative damage via activation of PI3K/Akt/eNOS pathway[J]. Exp Gerontol，2021，147：111270.

LI R，YIN H L，WANG J，et al. Dihydroartemisinin alle-viates skin fibrosis and endothelial dysfunction in bleomycin-induced skin fibrosis models[J]. Clin Rheumatol，2021，40（10）：4269-4277.

YANG B Q，GAO X L，SUN Y C，et al. Dihydroartemi-sinin alleviates high glucose-induced vascular smooth muscle cells proliferation and inflammation by depressing the miR-376b-3p/KLF15 pathway[J]. Biochem Biophys Res Commun，2020，530（3）：574-580.

JIANG Y Y，SHUI J C，ZHANG B X，et al. The potential roles of artemisinin and its derivatives in the treatment of type 2 diabetes mellitus[J]. Front Pharmacol，2020，11：585487.

CHEN Y，LI W，NONG X L，et al. Role of artesunate on cardiovascular complications in rats with type 1 diabetes mellitus[J]. BMC Endocr Disord，2021，21（1）：19.

李亚云，宗刚军，黄月皎. 青蒿素对心肌梗死大鼠心肌损伤及TLR4/MyD88/NF-κB p65信号通路的影响[J]. 中国煤炭工业医学杂志，2021，24（3）：225-230.

崔勤涛，王学惠，刘永强，等. 双氢青蒿素通过抑制蛋白激酶B和NF-κB p65磷酸化减轻缺血再灌注导致的小鼠心肌损伤[J]. 中国药理学与毒理学杂志，2021，35（4）：259-264.

KHAN A I，KAPOOR A，CHEN J M，et al. The antimalarial drug artesunate attenuates cardiac injury in a rodent model of myocardial infarction[J]. Shock，2018，49（6）：675-681.

CHEN Y Y，ZHENG S H，WANG Z W，et al. Artesunate restrains maturation of dendritic cells and ameliorates heart transplantation-induced acute rejection in mice through the PERK/ATF4/CHOP signaling pathway[J]. Mediators Inflamm，2021，2021：2481907.

YOON S S，KWON H W，SHIN J H，et al. Anti-thrombotic effects of artesunate through regulation of cAMP and PI3K/MAPK pathway on human platelets[J]. Int J Mol Sci，2022，23（3）：1586.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

经典名方天王补心丹治疗失眠的研究现状

土大黄的药理作用及临床应用研究进展

碳酸锂的临床应用及其毒性研究进展

银杏叶提取物对中枢神经系统保护作用的研究进展

银杏达莫注射液的药理作用及不良反应研究进展